It's a Self Licking Ice Cream Cone

The DEA has decided to keep classifying Marijuana as a Schedule 1 Drug, which means that they claim that it has no therapeutic value.

It also means that a large portion of the DEA's budget, the part that is driven by its anti-pot activities, remains safe.

How convenient:

For the fourth consecutive time, the Drug Enforcement Administration has denied a petition to lessen federal restrictions on the use of marijuana.

While recreational marijuana use is legal in four states and D.C., and medical applications of the drug have been approved in many more, under federal law, it remains a Schedule 1 controlled substance, which means it's considered to have "no currently accepted medical use" and a "high potential for abuse."

The gap between permissive state laws and a restrictive federal policy has become increasingly untenable in the minds of many doctors, patients, researchers, business owners and legislators.

For instance, last fall, a Brookings Institution report slammed the federal government for "stifling medical research" in the area of marijuana policy. As a Schedule 1 drug, it's much harder for researchers to work with marijuana than with many other controlled substances. The American Academy of Pediatrics has called on the government to move marijuana into Schedule 2 to facilitate more research into medical uses.

Perhaps this determination should be made by an organization whose budget is not contingent on it remaining illegal.